相关实验视频

Updated: Jun 27, 2025

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology

Published on: May 28, 2017

术后认知功能障碍与阿尔茨海默病的相关性进展,以及潜在的治疗药物探索

Dong-Qin Chen^1,2, Xu Fang^1,2, Zhao-Qiong Zhu¹

¹Department of Anesthesiology Affiliated Hospital of Zunyi Medical University Zunyi China.

|April 29, 2024

概括

手术后认知功能障碍 (POCD) 和阿尔茨海默氏症 (AD) 在神经炎症和蛋白质沉积方面具有潜在的联系. 需要进一步的研究来澄清它们之间的关系,并开发有效的治疗认知衰退.

科学领域:

神经科学是一个神经科学.
老年病的医生老年病的医生
麻醉学麻醉学

背景情况:

手术后认知功能障碍 (POCD) 是手术后精神能力的下降,具有潜在的长期影响.
阿尔茨海默病 (AD) 是一种与蛋白质和突触假设相关的渐进性神经退行性疾病,通常涉及神经炎症.
目前的理解表明,AD和POCD之间存在潜在的生物重叠,包括脑蛋白沉积和炎症途径.

研究的目的:

审查和比较AD和POCD的临床特征和病理生理机制.
探索阿尔茨海默病和术后认知功能障碍之间的潜在关系和共同点.
为了确定这些认知障碍的新治疗策略.

主要方法:

关于AD和POCD当前临床和病理生理学研究的文献综述.
分析共享的生物机制,包括神经炎症和蛋白质沉积.
对疾病特征和进展进行比较分析.

主要成果:

在POCD中麻醉深度和类型的作用似乎不像以前想象的那么重要.
共同的路径,如神经炎症和蛋白质聚合,可能会将AD和POCD联系起来.
阿尔茨海默病和POCD之间的确切病因关系仍然不确定,关于POCD是否是阿尔茨海默病进展的一部分,还是一个独特的实体,目前仍在争论.

结论:

阿尔茨海默病和术后认知功能障碍之间存在可信的生物学联系.
进一步研究共享机制对于理解和治疗这些疾病至关重要.
澄清AD和POCD之间的关系对于准确的诊断和有效的治疗开发至关重要.

关键词:

阿尔茨海默氏症的疾病是阿尔茨海默氏症.医疗治疗医疗治疗病变的发生和发病.术后认知功能障碍术后认知功能障碍

更多相关视频

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits

Published on: March 16, 2016

Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein

Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein

Published on: July 29, 2018

相关概念视频

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.

Dementia

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....

Cognitive Development During Adulthood

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...

Long-term Depression

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...